210 related articles for article (PubMed ID: 18453541)
1. TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction.
Yuen HF; Kwok WK; Chan KK; Chua CW; Chan YP; Chu YY; Wong YC; Wang X; Chan KW
Carcinogenesis; 2008 Aug; 29(8):1509-18. PubMed ID: 18453541
[TBL] [Abstract][Full Text] [Related]
2. Novel basic helix-loop-helix transcription factor hes4 antagonizes the function of twist-1 to regulate lineage commitment of bone marrow stromal/stem cells.
Cakouros D; Isenmann S; Hemming SE; Menicanin D; Camp E; Zannetinno AC; Gronthos S
Stem Cells Dev; 2015 Jun; 24(11):1297-308. PubMed ID: 25579220
[TBL] [Abstract][Full Text] [Related]
3. A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome.
Guenou H; Kaabeche K; Mée SL; Marie PJ
Hum Mol Genet; 2005 Jun; 14(11):1429-39. PubMed ID: 15829502
[TBL] [Abstract][Full Text] [Related]
4. Methyltransferase G9A Regulates Osteogenesis via Twist Gene Repression.
Higashihori N; Lehnertz B; Sampaio A; Underhill TM; Rossi F; Richman JM
J Dent Res; 2017 Sep; 96(10):1136-1144. PubMed ID: 28644763
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.
Dey P; Jonsson P; Hartman J; Williams C; Ström A; Gustafsson JÅ
Mol Endocrinol; 2012 Dec; 26(12):1991-2003. PubMed ID: 23028063
[TBL] [Abstract][Full Text] [Related]
6. Twist negatively regulates osteoblastic differentiation in human periodontal ligament cells.
Komaki M; Karakida T; Abe M; Oida S; Mimori K; Iwasaki K; Noguchi K; Oda S; Ishikawa I
J Cell Biochem; 2007 Feb; 100(2):303-14. PubMed ID: 16888803
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
8. The role of TWIST as a regulator in giant cell tumor of bone.
Singh S; Mak IW; Cowan RW; Turcotte R; Singh G; Ghert M
J Cell Biochem; 2011 Sep; 112(9):2287-95. PubMed ID: 21503964
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.
Kwok WK; Ling MT; Lee TW; Lau TC; Zhou C; Zhang X; Chua CW; Chan KW; Chan FL; Glackin C; Wong YC; Wang X
Cancer Res; 2005 Jun; 65(12):5153-62. PubMed ID: 15958559
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism for the regulation of osteoblast differentiation: transcription of periostin, a member of the fasciclin I family, is regulated by the bHLH transcription factor, twist.
Oshima A; Tanabe H; Yan T; Lowe GN; Glackin CA; Kudo A
J Cell Biochem; 2002; 86(4):792-804. PubMed ID: 12210745
[TBL] [Abstract][Full Text] [Related]
11. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
12. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.
Tan CC; Li GX; Tan LD; Du X; Li XQ; He R; Wang QS; Feng YM
Oncotarget; 2016 Nov; 7(48):79688-79705. PubMed ID: 27806311
[TBL] [Abstract][Full Text] [Related]
15. Effects of overexpression of basic helix-loop-helix transcription factor Dec1 on osteogenic and adipogenic differentiation of mesenchymal stem cells.
Iwata T; Kawamoto T; Sasabe E; Miyazaki K; Fujimoto K; Noshiro M; Kurihara H; Kato Y
Eur J Cell Biol; 2006 May; 85(5):423-31. PubMed ID: 16487626
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
Zayzafoon M; Abdulkadir SA; McDonald JM
J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
[TBL] [Abstract][Full Text] [Related]
17. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
18. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line.
Su SJ; Chang KL; Su SH; Yeh YT; Shyu HW; Chen KM
Int J Food Sci Nutr; 2013 Jun; 64(4):429-36. PubMed ID: 23301724
[TBL] [Abstract][Full Text] [Related]
19. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer cells promote osteoblastic bone metastases through Wnts.
Hall CL; Bafico A; Dai J; Aaronson SA; Keller ET
Cancer Res; 2005 Sep; 65(17):7554-60. PubMed ID: 16140917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]